Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 27, 2025 - Bio-Thera Solutions and Hikma announced the FDA approval of Starjemza (ustekinumab-hmny), biosimilar to Janssen’s Stelara® (ustekinumab).
Download PDF
Return to publications
